India  
 
NewsR.in

AstraZeneca admits Covishield vaccines raises rare side-effects risk. How worried should you be?

DNA Wednesday, 1 May 2024 ()
In India, almost 90% of people who received Covid vaccine, received the AstraZeneca vaccine which in India is called Covishield.
0
shares		ShareTweetSavePostSend
 
Video Credit: Oneindia - Published
News video: Covishield: Parents File Lawsuit Against Serum Institute Amid AstraZeneca’s Report| Oneindia

Covishield: Parents File Lawsuit Against Serum Institute Amid AstraZeneca’s Report| Oneindia 03:03

 After AstraZeneca's acknowledgment of rare side effects, parents of a woman allegedly deceased post-Covishield vaccination initiated legal action against Serum Institute of India. Covishield, developed by AstraZeneca and Oxford University, faced scrutiny. Another family shared the plight of their...

You Might Like


Related videos from verified sources

AstraZeneca Withdraws COVID-19 Vaccine Globally, Days After Side Effect Confession in UK Court [Video]

AstraZeneca Withdraws COVID-19 Vaccine Globally, Days After Side Effect Confession in UK Court

AstraZeneca has globally withdrawn its Covid vaccine, citing commercial reasons. The company voluntarily revoked its marketing authorization and announced the cessation of vaccine production, rendering..

Credit: Oneindia     Duration: 05:11Published
Political uproar in India after Astrazeneca admits blood clot side effect [Video]

Political uproar in India after Astrazeneca admits blood clot side effect

A political controversy has erupted in India after British pharma giant Astrazeneca admitted in the UK court that it's Covid-19 vaccine to blood clots in "very rare cases"...

Credit: Rumble     Duration: 06:02Published
Bombshell Astrazeneca Vaccine Faces Big Lawsuit Admit Side Effects Over Rare Blood Clot [Video]

Bombshell Astrazeneca Vaccine Faces Big Lawsuit Admit Side Effects Over Rare Blood Clot

Bombshell Astrazeneca Vaccine Faces Big Lawsuit Admit Side Effects Over Rare Blood Clot .. please like subscribe

Credit: Rumble     Duration: 02:02Published

Related news from verified sources

Bharat Biotech stresses on Covaxin’s safety record after AstraZeneca admits to Covishield causing rare clotting side effects

 Following AstraZeneca's acknowledgment in a UK court that its Covid-19 vaccine triggered a rare side effect—Thrombosis with Thrombocytopenia Syndrome (TTS),...
IndiaTimes